Eight major players in Japan’s chemical sector have finalized their accounts for April–September 2019. Facing the direct impact of a…...
Please subscribe to read the full story.
Novartis
Anaeropharma Makes Progress With US Clinical Trials of New Anti-Cancer Drug
Anaeropharma Science Inc., a venture originating at Shinshu University, is set to advance its development of Bifidobacterium-based anti-cancer drug APS001F…....
Please subscribe to read the full story.
Daiichi Sankyo Sees Pillar of Growth in Next-Gen Biopharmaceuticals
Daiichi Sankyo Co. Ltd. (TYO:4568) is making antibody drug conjugates (ADCs) and other next-generation biopharmaceuticals a pillar for medium- and…...
Please subscribe to read the full story.
